{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:27:24Z","timestamp":1790800044788,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Prescribing pharmaceuticals is essential to improve health, but it also has substantial environmental impact. This study investigated the extent to which Swedish general practitioners (GPs) are willing to integrate environmental aspects into treatment decisions and their opinions on policies to reduce pharmaceutical pollution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A questionnaire assessing environmental considerations in prescribing was developed and distributed to 1233 Swedish GPs and physicians in training (response rate: 22%) between September 2023 and June 2024. It included 3 patient cases to assess trade\u2010offs between therapeutic effect and environmental impact of pharmaceuticals used for pain management, blood pressure reduction, and contraception. Questions about attitudes to policies to reduce the environmental impact of pharmaceuticals were also included. Data were analysed using descriptive and inferential statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most respondents were willing to prescribe a less effective pharmaceutical if it was environmentally preferable, 77% for pain management and blood pressure reduction, and 50% for contraception. Environmental impact was ranked as the least important factor in prescribing decisions when compared to cost, regional treatment guidelines, dosage intervals, and user\u2010friendliness. A total of 68% of respondents agreed that physicians should consider environmental aspects when prescribing, however only a few often searched for environmental information when prescribing. Policies directed towards other stakeholders, such as authorities and the pharmaceutical industry, received substantial support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Swedish GPs are willing to consider environmental factors when prescribing. However, other factors are more often considered and GPs attribute higher responsibility to other actors. Improving access to environmental information about pharmaceuticals could support greener prescribing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70066","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T23:35:27Z","timestamp":1745796927000},"page":"1623-1631","source":"Crossref","is-referenced-by-count":7,"title":["Towards greener prescribing? Swedish general practitioners' support for policies to reduce pharmaceutical pollution"],"prefix":"10.1002","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9778-0573","authenticated-orcid":false,"given":"Johanna","family":"Vill\u00e9n","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Laux","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Institute of Pharmacy, Medical Faculty Leipzig University  Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy Uppsala University  Uppsala Sweden"},{"name":"Pharmacy and Pharmacology Center, Institute of Biomedical Science, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia K\u00e4lvemark","family":"Sporrong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marmar","family":"Nekoro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy Uppsala University  Uppsala Sweden"},{"name":"Swedish Medical Products Agency  Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"H\u00e5konsen","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, Institute of Medicine University of Gothenburg  Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1289\/EHP.1104477"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1897\/08\u2010382.1"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113947119"},{"key":"e_1_2_11_5_1","unstructured":"MalnesD GolovkoO K\u00f6hlerS AhrensL.F\u00f6rekomst Av Organiska Milj\u00f6f\u00f6reningar i Svenska Ytvatten. Kartl\u00e4ggning Av Sveriges Tre St\u00f6rsta Sj\u00f6ar Tillrinnande Vattendrag Och Utlopp [Occurrence of Organic Environmental Compounds in Swedish Surface Water. Mapping of Sweden's Three Largest Lakes].;2021. Accessed October 12 2024.https:\/\/pub.epsilon.slu.se\/22203\/1\/malnes_d_et_al_210207.pdf"},{"key":"e_1_2_11_6_1","unstructured":"Swedish Agency for Marine and Water Management.Havs\u2010 Och Vattenmyndighetens F\u00f6reskrifter Om Klassificering Och Milj\u00f6kvalitetsnormer Avseende Ytvatten; HVMFS 2019:25 [The Swedish Sea and Water Authority's Regulations on Classification and Environmental Quality Standards Regarding Surface Water].;2020. Accessed November 25 2024.https:\/\/www.havochvatten.se\/vagledning-foreskrifter-och-lagar\/foreskrifter\/register-vattenforvaltning\/klassificering-och-miljokvalitetsnormer-avseende-ytvatten-hvmfs-201925.html"},{"key":"e_1_2_11_7_1","unstructured":"European Commission.A European Green Deal: striving to be the first climate\u2010neutral continent. Accessed December 12 2024.https:\/\/commission.europa.eu\/strategy-and-policy\/priorities-2019-2024\/european-green-deal_en"},{"key":"e_1_2_11_8_1","unstructured":"European Commission.Strategic Approach to Pharmaceuticals in the Environment. 11.3.2019 COM(2019) 128 final. Published2019. Accessed December 12 2024.https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52019DC0128&qid=1605854880622"},{"key":"e_1_2_11_9_1","unstructured":"MistraPharma Research.Final Report: Identification and Reduction of Environmental Risks Caused by Human Pharmaceuticals. Accessed November 25 2024.https:\/\/mistra.org\/wp-content\/uploads\/2022\/12\/MistraPharma-FinalReport-2008-2015-ENG.pdf"},{"key":"e_1_2_11_10_1","unstructured":"The Swedish Medical Products Agency.Redovisning Av Regeringsuppdrag Avseende Milj\u00f6skadlighet F\u00f6r Receptfria L\u00e4kemedel (Dnr: S2021\/01905 [Delvis]) [Government Assignment Regarding Environmental Damage for over\u2010the\u2010Counter Medicines].;2021."},{"key":"e_1_2_11_11_1","unstructured":"The Swedish dental and pharmaceutical benefits agency.F\u00f6rs\u00f6ksverksamhet F\u00f6r En Milj\u00f6premie i F\u00f6rm\u00e5nssystemet [trial operation for a environmental premium in the benefits system]Dnr: 1505\/2021.;2021."},{"key":"e_1_2_11_12_1","unstructured":"Region Stockholm.Pharmaceuticals and Environment \u2010 Janusinfo. Accessed December 10 2024.https:\/\/janusinfo.se\/beslutsstod\/lakemedelochmiljo\/pharmaceuticalsandenvironment.4.7b57ecc216251fae47487d9a.html"},{"key":"e_1_2_11_13_1","unstructured":"Fass.Information till v\u00e5rdpersonal [Information to health care professionals]. Accessed December 10 2024.https:\/\/www.fass.se\/LIF\/startpage?userType=0"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010020\u201002885\u20101\/Published"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102016"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1742\u20107843.2011.00682.X"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riae073"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102020\u2010041460"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2006.07.007"},{"key":"e_1_2_11_20_1","unstructured":"SketrisI Ingram LangilleE LummisH.Optimal prescribing and medication\u2010use in Canada: Challenges and Opportunities;2007."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1308\/RCSANN.2021.0271"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12630\u2010018\u201001273\u20109"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/1355819617697353"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000000267"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25198"},{"key":"e_1_2_11_26_1","unstructured":"Janl\u00f6vN BlumeS Glenng\u00e5rdAH HanspersK AnellA MerkurS.Sweden: Health SystemReview;2023. Accessed December 12 2024.https:\/\/iris.who.int\/bitstream\/handle\/10665\/372708\/9789289059473-eng.pdf?sequence=8"},{"issue":"3","key":"e_1_2_11_27_1","first-page":"207","article-title":"Drug and therapeutics committees: a Swedish experience","volume":"13","author":"Sjoqvist F","year":"2002","journal-title":"WHO Drug Inform"},{"key":"e_1_2_11_28_1","unstructured":"OlssonAC IsacssonA KolmodinL.Swedish Association of Local Authorities and Regions: L\u00e4kartillg\u00e5ng i Prim\u00e4rv\u00e5rden [Access to Doctors in Primary Care].;2022. Accessed December 12 2024.https:\/\/skr.se\/download\/18.1fe145c3183790beec051065\/1664887612060\/Lakartillgang-i-prim\u00e4rvarden2021.pdf"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.ENVADV.2023.100358"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476\u2010069X\u201012\u201045"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471654728"},{"key":"e_1_2_11_32_1","unstructured":"R Core Team.R: a language and environment for statistical computing. Published Online2021.https:\/\/www.r-project.org\/"},{"key":"e_1_2_11_33_1","unstructured":"Doctors for the environment [L\u00e4kare f\u00f6r milj\u00f6n]. Accessed December 10 2024.https:\/\/lakareformiljon.se\/"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/su132212930"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102019\u2010035502"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1540\u20106237.2008.00574.X"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4246"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70066","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:37:16Z","timestamp":1782481036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":36,"aliases":["10.1111\/bcp.70066"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/bcp.70066"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70066","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]}}}